Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» US FDA committee recommends expanded approval for Eli Lilly's Cymbalta to a broader pain population
US FDA committee recommends expanded approval for Eli Lilly's Cymbalta to a broader pain population
US FDA committee recommends expanded approval for Eli Lilly's Cymbalta to a broader pain population
Submitted by
admin
on August 21, 2010 - 1:51pm
Source:
Pharmabiz
News Tags:
Eli Lilly
Cymbalta
pain management
Headline:
US FDA committee recommends expanded approval for Eli Lilly's Cymbalta to a broader pain population
Do Not Allow Advertisers to Use My Personal information
